Envenom Pharm
FITNESS PRODUCTS
Free call (Russia only)
8 (800) 707-88-09
Request a call back

Sarmastol

< Назад

Sarmastol

Conclusion on the results of the study sample drug Sarmastol

Director of the Federal State Unitary Enterprise "Research Institute of Hygiene, Occupational Pathology and Human Ecology" of the Federal Medical-Biological Agency, doctor of medical sciences, professor.

V.R. Rembovsky

2017

  The purpose of the research: authentication of Sarmastol pharmaceuticals.  

  Samples provided by: Envenom Pharm.  

  Research Object: Dosage Form - Capsules  

  Components Detected: AC-262536  

  Research Method: High performance liquid chromatography with mass spectrometric detection in high resolution mode. Measuring instruments: High-resolution HPLC-MS/MS by Thermo Scienti fi c (USA), DionexUltiMate 3000 chromatograph and Q Exactive mass spectrometer (HESI-II B electrospray, positive ionization mode)  

  Brief description of the sample submitted for analysis
  Trade name of the drug: Sarmastol. Dosage form - capsules. &Nbsp;

  Appearance of the drug: powder in a white capsule.  

  Active ingredient: AC-262536, gross formula: С 18 H 18 N 2 O

  Sample Preparation for HPLC Analysis  
 
The capsule was dissolved in 5 ml of methanol (pure for HPLC). The prepared solution was diluted with methanol 100 times and analyzed with 5 µl by HPLC-MS high resolution. &Nbsp;

  Equipment and conditions for HPLC-MS analysis
Liquid chromatograph UltiMate 3000, with a mass-selective detector Q-Exactive. Ionization mode: electrospray ionization. The chromatograph is equipped with a Zorbax SB-C8 column with a length of 15 cm, an inner diameter of 4.6 mm, and a particle size of 1.8 μm. The gradient elution mode: eluent A - 0.1% solution of formic acid in water, eluent B - acetonitrile. &Nbsp;

The ratios of the components of the mobile phase are presented in Table 1. The volumetric rate of the mobile phase through the column is 0.4 ml/min. The temperature of the column thermostat is 35 ° C. The volume of sample injected for analysis of 5 µl.

  Table 1. The ratio of the components of the mobile phase

 
  Time  % B
      0       10
      5       10
      20       90
      40       90
      40.1       10
      45       10

  Working conditions of the mass selective detector: dehydrator gas flow 45 cu The auxiliary gas flow is $ 12. 35 psi spray pressure. The temperature of the gas desiccant 350 ° C. The temperature of the auxiliary flow 400 ° C. Voltage on the capillary 35008. Detection was carried out in the scan mode for the total ion current (SCAN): registration of ions in the m/z range from 100 to 1500 in positive ionization.

  Identification of the components of the sample by high-resolution HPLC-MS method Components were identified by the exact mass of the corresponding protonated molecular ion [M + H] +. Figure 1 shows the mass chromatogram and the mass spectrum obtained by analyzing the sample solution of the drug by the HPLC-MS method, reconstructed from the exact mass of AC-262536 [M + H] + .- 279.14919.

  Figure 1 - Mass spectrum and mass chromatogram of a solution of a sample of the Sarmastol preparation, reconstructed according to the exact mass. АЗЗ-262536 [М + Н] + - 279.14919
 
sarmastol.svg

A chromatographic peak with a retention time of 22.18 minutes corresponds to the compound to be detected. The experimentally recorded mass of 279.1491 deviation from the theoretical is less than 0.1 ppm. Measurement error of the exact mass and elemental composition of the ion (the difference between the measured mass and the calculated one) < 5 ppm, which indicates reliable identification.

  Conclusion
As a result of the conducted research, it was confirmed that the sample of Sarmastol preparation presented for research contains AC-262536.